David P. Nunes, MD

Associate Professor, Medicine

David Nunes
(617) 638-6525
85 E. Concord St

Biography

Expertise includes: Clinical liver disease – interest in viral hepatitis; Evaluation and management of liver lesions.

Other Positions

  • Active Staff Privileges, Medicine, Boston Medical Center

Education

  • Trinity College, MBBCh

Publications

  • Published on 12/31/2015

    Baranoski AS, Cotton D, Heeren T, Nunes D, Kubiak RW, Horsburgh CR. Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men. Open Forum Infect Dis. 2016 Jan; 3(1):ofv214. PMID: 26955643.

    Read at: PubMed
  • Published on 2/28/2015

    Anderson JP, Horsburgh CR, Williams PL, Tchetgen Tchetgen EJ, Nunes D, Cotton D, Seage GR. CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users. Open Forum Infect Dis. 2015 Jan; 2(1):ofv019. PMID: 26034769.

    Read at: PubMed
  • Published on 10/24/2013

    Fuster D, Cheng DM, Quinn EK, Nunes D, Saitz R, Samet JH, Tsui JI. Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems. Addiction. 2014 Jan; 109(1):62-70. PMID: 24112091.

    Read at: PubMed
  • Published on 7/1/2013

    Okafor PN, Nunes DP, Farraye FA. Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered? Inflamm Bowel Dis. 2013 Jul; 19(8):1764-71. PMID: 23615530.

    Read at: PubMed
  • Published on 5/17/2013

    Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems. AIDS Res Hum Retroviruses. 2013 Aug; 29(8):1110-6. PMID: 23601055.

    Read at: PubMed
  • Published on 5/3/2013

    Fuster D, Tsui JI, Cheng DM, Quinn EK, Bridden C, Nunes D, Libman H, Saitz R, Samet JH. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection. Alcohol Clin Exp Res. 2013 Sep; 37(9):1527-35. PMID: 23647488.

    Read at: PubMed
  • Published on 6/22/2011

    Pereira C, Yalçin A, Cretich M, Chiari M, Unlü MS, Nunes D, Bergstein DA. Synergetic chemiluminescence and label-free dual detection for developing a hepatitis protein array. J Immunol Methods. 2011 Aug 31; 371(1-2):159-64. PMID: 21718699.

    Read at: PubMed
  • Published on 2/23/2010

    Nunes D, Fleming C, Offner G, Craven D, Fix O, Heeren T, Koziel MJ, Graham C, Tumilty S, Skolnik P, Stuver S, Horsburgh CR, Cotton D. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol. 2010 Jun; 105(6):1346-53. PMID: 20179698.

    Read at: PubMed
  • Published on 9/1/2008

    Pungpapong S, Nunes DP, Krishna M, Nakhleh R, Chambers K, Ghabril M, Dickson RC, Hughes CB, Steers J, Nguyen JH, Keaveny AP. Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl. 2008 Sep; 14(9):1294-302. PMID: 18756457.

    Read at: PubMed
  • Published on 7/10/2008

    Sullivan LE, Saitz R, Cheng DM, Libman H, Nunes D, Samet JH. The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients. Addiction. 2008 Sep; 103(9):1461-7. PMID: 18637000.

    Read at: PubMed

View 42 more publications: View full profile at BUMC

View all profiles